SFTA1P and hepatocellular carcinoma: In gastric cancer, SFTA1P acts as a tumor suppressor by influencing cell proliferation and migration via down-regulating TP53 [25], while in hepatocellular carcinoma, SFTA1P acts more like an oncogene by down-regulating miR-4766-5p via the PI3K/AKT/mTOR signaling pathway [26].